アジア太平洋地域核医学市場規模、シェア、競合情勢、トレンド分析レポート：製品別（診断薬、治療薬）、用途別（腫瘍学、神経学、心臓病学、その他）： 2025年から2033年までの機会分析および業界予測

レポートID : ROJP0425564 | 最終更新 : 2025年04月 | フォーマット : : :

Asia-Pacific Nuclear Medicine Market Report - Table of Contents

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
- 4.2.1 Growth in the Prevalence of Cancer and Heart Disorders Propels the Market's Expansion
4.3 Market Restraints
- 4.3.1 Delay in the Regulatory Environment May Impede the Growth of the Market
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

5.1 By Product
- 5.1.1 Diagnostics
- 5.1.1.1 Positron Emission Tomography
- 5.1.1.2 Single Photon Emission Computed Tomography
- 5.1.2 Therapeutics
- 5.1.2.1 Brachytherapy
- 5.1.2.2 Alpha Emitters
- 5.1.2.3 Beta Emitters
5.2 By Application
- 5.2.1 Oncology
- 5.2.2 Neurology
- 5.2.3 Cardiology
- 5.2.4 Other Applications
5.3 Geography
- 5.3.1 China
- 5.3.2 Japan
- 5.3.3 India
- 5.3.4 Australia
- 5.3.5 South Korea
- 5.3.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS